share_log

藥明康德：海外監管公告

WUXI APPTEC: An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

香港交易所 ·  Mar 19 06:19
Summary by Moomoo AI
無錫藥明康德於2024年3月20日宣布，已於同年2月5日完成回購並注銷全部A股股份20,275,407股，以維護公司價值及股東權益。該行動經第三屆董事會第七次會議審議通過，並已於2月2日及2月6日在上海證券交易所網站及指定媒體公告。注銷股份後，公司的股本發生變動，但流通股數量維持不變。公示期間，公司未收到债权人申報债权。本次股份注銷並減少註冊資本的相關變更登記手續已妥善辦理。
無錫藥明康德於2024年3月20日宣布，已於同年2月5日完成回購並注銷全部A股股份20,275,407股，以維護公司價值及股東權益。該行動經第三屆董事會第七次會議審議通過，並已於2月2日及2月6日在上海證券交易所網站及指定媒體公告。注銷股份後，公司的股本發生變動，但流通股數量維持不變。公示期間，公司未收到债权人申報债权。本次股份注銷並減少註冊資本的相關變更登記手續已妥善辦理。
Wuxi Pharmaceutical Ming Kand announced on March 20, 2024 that it had completed the repurchase and repurchase of 20,275,407 shares of all A shares on February 5 of the same year in order to preserve the company's value and shareholders' interests. The action was approved by the Seventh Meeting of the Third Board of Directors and was announced on the Shanghai Stock Exchange website and designated media on 2 February and 6 February. After the repurchase of shares, the share capital of the company changed, but the number of outstanding shares remained unchanged. During the announcement period, the company did not receive the debtor's declaration of debt. The registration procedures relating to the repurchase of shares and the reduction of registered capital have been duly completed.
Wuxi Pharmaceutical Ming Kand announced on March 20, 2024 that it had completed the repurchase and repurchase of 20,275,407 shares of all A shares on February 5 of the same year in order to preserve the company's value and shareholders' interests. The action was approved by the Seventh Meeting of the Third Board of Directors and was announced on the Shanghai Stock Exchange website and designated media on 2 February and 6 February. After the repurchase of shares, the share capital of the company changed, but the number of outstanding shares remained unchanged. During the announcement period, the company did not receive the debtor's declaration of debt. The registration procedures relating to the repurchase of shares and the reduction of registered capital have been duly completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more